… of “Cytokine Storm Syndrome” (CSS), multi-organ-failure and death. Given that currently
the treatment of … the cytokine storm might be beneficial as an adjunct treatment of SARS-CoV-2. …

… interference with the cytokine storm as a therapeutic approach to tackle COVID-19. In this …
into the cytokine storm phenomena as one of the key players to COVID-19 aggressiveness and …

… , but inhibit cytokines including IL-6 and GM-CSF in COVID-19-associated CRS, JAK2
inhibition is likely to offer an attractive therapeutic option for blocking cytokine storm in COVID-19. …

… a central cellular pro-inflammatory signal pathway, NF-κB, in … where eight (or more) treatment
cycles are routinely applied, … downregulate the acute cytokine storm in COVID-19 patients, …

… COVID-19 epidemiological profile, the molecular mechanisms of the SARS-CoV-2-induced
cytokine storm … compounds used in treatment strategies and the potential drugs for targeting …

… properties can suppress cytokine storm associated with … will summarize cytokine storm of
the COVID-19 patients and … in treating and mitigating the cytokine storm in COVID-19 patients. …

… Plasma therapy has been used in prior viral pandemics such as pandemic influenza A (H1N1)…
treatments that specifically aim to target the cytokine storm in the battle against COVID-19. …

… can be explored to control the cytokine storm observed in COVID-19. … signalling pathways
namely the mitogen-activated protein kinase (MAPK) pathway [75] and the JAK/STAT pathway …

… the cytokine storm in patients with COVID-19 (38). Previously, Shakoory B, et al. (39) claimed
that the administration of Anakinra intravenously at a dose of 2.0 mg/kg/h for 72 h could …

… IL-6, and TNF-α are considered harmful cytokines and are involved in the generation of
cytokine storms during the COVID-19 … the cytokine storm in critically ill patients with COVID-19. …